Peer Review reports
From: ROS as a novel indicator to predict anticancer drug efficacy
| Original Submission | ||
|---|---|---|
| 4 Jul 2019 | Submitted | Original manuscript |
| 6 Aug 2019 | Reviewed | Reviewer Report - Sankarprasad Bhuniya |
| 16 Aug 2019 | Reviewed | Reviewer Report - Sunil Badve |
| 16 Sep 2019 | Author responded | Author comments - Tarek Zaidieh |
| Resubmission - Version 2 | ||
| 16 Sep 2019 | Submitted | Manuscript version 2 |
| 7 Oct 2019 | Reviewed | Reviewer Report - Sankarprasad Bhuniya |
| 22 Oct 2019 | Reviewed | Reviewer Report - Ivan Pavlović |
| 30 Oct 2019 | Reviewed | Reviewer Report - Willem Corver |
| 19 Nov 2019 | Author responded | Author comments - Tarek Zaidieh |
| Resubmission - Version 3 | ||
| 19 Nov 2019 | Submitted | Manuscript version 3 |
| 3 Dec 2019 | Author responded | Author comments - Tarek Zaidieh |
| Resubmission - Version 4 | ||
| 3 Dec 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 5 Dec 2019 | Editorially accepted | |
| 16 Dec 2019 | Article published | 10.1186/s12885-019-6438-y |
You can find further information about peer review here.